Exploring Bladder-Sparing Treatment Approaches in MIBC скачать в хорошем качестве

Exploring Bladder-Sparing Treatment Approaches in MIBC

In the fourth part of this roundtable series, the panelists discuss recent updates on bladder-sparing treatments, including immunotherapy with chemoradiation and the combination of gemcitabine/cisplatin/nivolumab without cystectomy. A roundtable moderated by Karine Tawagi, MD, of the University of Illinois, featured discussion on the treatment landscape of muscle invasive and non-muscle invasive bladder cancer. Panelists Petros Grivas, MD, PhD, of Fred Hutchinson Cancer Center, and Vadim Koshkin, MD, of the University of California, San Francisco discussed some of the latest practice-changing trials in the treatment landscape, as well as the potential of bladder-sparing treatment approaches and the use of ctDNA.